The product you are interested in comes in a 10 milligram dose of KPV peptide, packaged as a single vial containing 3 milliliters of lyophilized powder. The packaging is designed to preserve the stability and integrity of the peptide until it is reconstituted by the user. Each vial contains exactly 10 mg of the pure peptide in powdered form, ready for dissolution.
KPV (10mg) can be used in a variety of experimental protocols. Researchers frequently employ this dose when investigating cellular responses to inflammatory stimuli, as the tripeptide has been shown to modulate cytokine production and reduce oxidative stress. The lyophilized format ensures that the peptide remains stable over extended storage periods, provided it is kept at recommended temperatures (usually −20°C or colder) and protected from moisture.
The contents of each vial are strictly controlled: marshallcountyalabamademocraticparty.com 10 mg of KPV tripeptide in a lyophilized state, with no added excipients or stabilizers. This pure form allows investigators to accurately calculate the concentration upon reconstitution. Typically, users add an appropriate volume of sterile diluent—often between 0.5 mL and 1.0 mL—to achieve a final solution that can be used in cell culture experiments or animal studies.
When preparing the peptide for use, it is important to follow good laboratory practices. First, verify the vial’s integrity; the powder should appear fine and free of clumps. Next, add the diluent slowly while gently swirling the vial to ensure complete dissolution. After reconstitution, the solution can be aliquoted into smaller volumes to avoid repeated freeze-thaw cycles that may degrade the peptide.
In summary, KPV (10mg) is supplied as a lyophilized powder in a 3 mL vial, offering researchers a stable and convenient source of this anti-inflammatory tripeptide for various experimental applications.
